Gemayel says that aside from the giveaway, Roche has a clear marketing message for the new treatment, which combats hepatitisC virus and the chronic liver disease it causes.
Though all types of viral hepatitis are associated with serious health issues, hepatitis B and C can become chronic infections that often lead to liver cirrhosis or liver cancer.